1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nagadoi, A. Nakazawa, K. Uda, H. Maekawa, T. Ishii, S. Nishimura, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 287 593 607 10.1006/jmbi.1999.2620 10092462 Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. 1999 US Genes Dev. GEDEEP 2056 0890-9369 4 682 Erratum. Transcription Factor ATF Cdna Clones: An Extensive Family of Leucine Zipper Proteins Able to Selectively Form DNA-Binding Heterodimers 1990 US Genes Dev. GEDEEP 2056 0890-9369 3 2083 Transcription Factor ATF Cdna Clones: An Extensive Family of Leucine Zipper Proteins Able to Selectively Form DNA-Binding Heterodimers 1989 UK Embo J. EMJODG 0897 0261-4189 8 2023 Leucine Zipper Structure of the Protein Cre-BP1 Binding to the Cyclic AMP Response Element in Brain 1989 10.2210/pdb1bhi/pdb pdb_00001bhi 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4336.971 CRE-BP1 ZINC FINGER-LIKE SUBDOMAIN OF THE TRANSACTIVATION DOMAIN 1 man polymer ATF-2 no no MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFG MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample CDNA 9606 Homo sapiens 511693 Escherichia coli BL21 BL21 PAR2156NCO1 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1999-06-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1998-06-09 REL REL THE STRUCTURES OF N- AND C-TERMINI OF THE PEPTIDE FRAGMENT (MET 1 - PRO 6 AND LYS 36 - GLY 38) WERE DISORDERED AMONG THE 20 STRUCTURES. THE 20 FINAL STRUCTURES EXHIBITED NO DISTANCE RESTRAINT VIOLATIONS GREATER THAN 0.1 ANGSTROMS AND DIHEDRAL ANGLE VIOLATIONS GREATER THAN 6.0 DEGREES. 100 20 6.3 300 K SIMULATED ANNEALING, ENERGY MINIMIZATION NAKAI,KIDERA,NAKAMURA refinement EMBOSS structure solution EMBOSS 600 Bruker DMX-600 MET 1 n 1 MET 1 A SER 2 n 2 SER 2 A ASP 3 n 3 ASP 3 A ASP 4 n 4 ASP 4 A LYS 5 n 5 LYS 5 A PRO 6 n 6 PRO 6 A PHE 7 n 7 PHE 7 A LEU 8 n 8 LEU 8 A CYS 9 n 9 CYS 9 A THR 10 n 10 THR 10 A ALA 11 n 11 ALA 11 A PRO 12 n 12 PRO 12 A GLY 13 n 13 GLY 13 A CYS 14 n 14 CYS 14 A GLY 15 n 15 GLY 15 A GLN 16 n 16 GLN 16 A ARG 17 n 17 ARG 17 A PHE 18 n 18 PHE 18 A THR 19 n 19 THR 19 A ASN 20 n 20 ASN 20 A GLU 21 n 21 GLU 21 A ASP 22 n 22 ASP 22 A HIS 23 n 23 HIS 23 A LEU 24 n 24 LEU 24 A ALA 25 n 25 ALA 25 A VAL 26 n 26 VAL 26 A HIS 27 n 27 HIS 27 A LYS 28 n 28 LYS 28 A HIS 29 n 29 HIS 29 A LYS 30 n 30 LYS 30 A HIS 31 n 31 HIS 31 A GLU 32 n 32 GLU 32 A MET 33 n 33 MET 33 A THR 34 n 34 THR 34 A LEU 35 n 35 LEU 35 A LYS 36 n 36 LYS 36 A PHE 37 n 37 PHE 37 A GLY 38 n 38 GLY 38 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O PHE 7 A O PHE 7 A N PHE 18 A N PHE 18 1 A ASP 3 -118.77 78.85 1 A LYS 5 57.45 76.02 2 A SER 2 55.80 -127.02 2 A ASP 4 65.51 -77.02 2 A PRO 12 -67.13 -75.00 2 A LEU 35 69.62 136.96 3 A ASP 4 55.72 97.49 3 A LYS 5 69.83 153.38 3 A PRO 6 -65.64 -171.04 3 A THR 34 44.59 72.04 3 A LEU 35 66.54 64.61 3 A LYS 36 -152.65 -51.27 3 A PHE 37 -155.18 26.42 4 A CYS 9 -68.64 94.29 4 A PRO 12 -67.49 -76.79 5 A SER 2 76.28 -53.64 5 A THR 10 -54.12 108.32 5 A PRO 12 -69.74 -78.80 5 A CYS 14 -151.35 -72.91 5 A THR 34 -134.55 -59.24 5 A LYS 36 48.17 -162.51 5 A PHE 37 -158.77 -48.52 6 A MET 33 -77.00 45.49 6 A LEU 35 -149.05 32.15 7 A PRO 12 -66.84 -73.05 8 A ASP 4 43.79 -109.23 8 A CYS 14 -84.88 45.79 8 A LEU 35 -119.83 77.23 8 A PHE 37 -150.10 -52.46 9 A PRO 12 -69.41 -80.65 9 A CYS 14 -152.80 -75.15 9 A THR 34 -168.11 -134.98 9 A LEU 35 -142.78 48.82 10 A CYS 14 -69.39 -70.52 10 A LEU 35 -166.76 71.27 10 A LYS 36 -163.27 91.70 11 A ASP 3 65.55 166.98 11 A LYS 36 -172.03 -105.93 11 A PHE 37 -166.19 -149.27 12 A PRO 12 -67.53 -70.09 12 A CYS 14 -156.84 40.05 12 A LEU 35 -152.53 40.33 12 A PHE 37 -159.91 -67.22 13 A THR 34 -151.58 68.12 13 A LYS 36 -164.15 109.20 14 A ASP 4 -140.28 29.81 14 A LYS 5 48.28 71.04 14 A PRO 12 -67.33 -73.94 14 A THR 34 174.69 -25.85 14 A PHE 37 75.88 -51.32 15 A SER 2 -77.10 -79.42 15 A ASP 3 36.24 50.87 15 A LYS 5 70.14 116.85 15 A PRO 6 -65.64 -175.91 15 A PRO 12 -67.32 -76.11 16 A SER 2 -162.57 -158.65 16 A THR 34 75.54 -47.10 16 A LEU 35 -156.46 -17.72 17 A PRO 12 -69.30 -80.92 17 A CYS 14 -151.85 -73.77 17 A LEU 35 -157.13 -55.99 17 A PHE 37 -101.54 46.86 18 A PHE 37 -158.19 -53.80 19 A ASP 3 -81.47 47.24 19 A PRO 12 -69.24 -76.57 19 A CYS 14 -151.22 -64.32 19 A PHE 37 -109.73 79.74 20 A ASP 3 65.60 -75.85 20 A LYS 5 52.31 73.68 20 A PHE 37 61.35 89.47 STRUCTURE OF TRANSACTIVATION DOMAIN OF CRE-BP1/ATF-2, NMR, 20 STRUCTURES 1 Y N A GLU 21 A GLU 21 HELX_P A GLU 32 A GLU 32 1 H1 12 DNA-BINDING REGULATORY PROTEIN CRE BINDING PROTEIN, ATF-2, TRANSCRIPTIONAL ACTIVATION DOMAIN, ZN FINGER, DNA-BINDING REGULATORY PROTEIN ATF2_HUMAN UNP 1 1 P15336 MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARNDSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKK ASEDDIKKMPLDLSPLATPIIRSKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTS SDSSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPSGQTMPVAIPASITSSNVHVPAAVPLVRPVTMVPSV PGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGSGLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQS TSGRRRRAANEDPDEKRRKFLERNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDC PVTAMQKKSGYHTADKDDSSEDISVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQMADQSTEPALSQIVMAPSS QSQPSGS 1 38 1BHI 1 38 P15336 A 1 1 38 2 anti-parallel A PHE 7 A PHE 7 A CYS 9 A CYS 9 A GLN 16 A GLN 16 A PHE 18 A PHE 18 1 P 1